FDA.reportPublic FDA data

24 HR Exalgo 8 MG Extended Release Oral Tablet

RxCUI
902743
RxNorm name
24 HR Exalgo 8 MG Extended Release Oral Tablet
Display name
24 HR Exalgo 8 MG Extended Release Oral Tablet
Full name
24 HR Exalgo 8 MG Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0dedd480-dc5c-499c-8763-6044b9bd4a6bExalgo 8 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR hydromorphone hydrochloride 8 MG Extended Release Oral Tablet [Exalgo] [SBD] · 24 HR Exalgo 8 MG Extended Release Oral Tablet [SY] · Exalgo 8 MG 24 HR Extended Release Oral Tablet [SY]41These highlights do not include all the information needed to use EXALGO ® safely and effectively. See full prescribing information for EXALGO. EXALGO (hydromorphone HCl) Extended-Release Tablets, for oral use, CII Initial U.S. Approval: 198420130128
f26ababe-f6f0-443e-8d91-4d2a174675bcExalgo 8 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR hydromorphone hydrochloride 8 MG Extended Release Oral Tablet [Exalgo] [SBD] · 24 HR Exalgo 8 MG Extended Release Oral Tablet [SY] · Exalgo 8 MG 24 HR Extended Release Oral Tablet [SY]41These highlights do not include all the information needed to use EXALGO™ safely and effectively. See full prescribing information for EXALGO. EXALGO (hydromorphone HCl) Extended-Release Tablets, CII Initial U.S. Approval: 198420111129